Dr. Julie Decock received her Master of Science (MSc) in Biomedical Sciences from the Free University of Brussels (VUB, Belgium) and completed her Doctor of Philosophy (PhD) in Medical Sciences at the Catholic University of Leuven, KU Leuven, Belgium. Her doctoral research focused on the cancer degradome, the repertoire of proteases in the tumor microenvironment that contribute to shaping the extracellular environment and modulating pericellular signaling, thereby affecting tumor progression and clinical outcome. Prior to moving to Qatar, she was a postdoctoral fellow at the University of East Anglia (UK) where she studied the role of several protease families in cancer.
Dr Decock’s research focuses on advancing our current understanding of breast cancer to help accelerate the breast cancer field and advance the development of new treatments. Dr. Decock is the recipient of several research grants and her track-record includes over 2600 citations.
Dr. Julie Decock received her Master of Science (MSc) in Biomedical Sciences from the Free University of Brussels (VUB, Belgium) and completed her Doctor of Philosophy (PhD) in Medical Sciences at the Catholic University of Leuven, KU Leuven, Belgium. Her doctoral research focused on the cancer degradome, the repertoire of proteases in the tumor microenvironment that contribute to shaping the extracellular environment and modulating pericellular signaling, thereby affecting tumor progression and clinical outcome. Prior to moving to Qatar, she was a postdoctoral fellow at the University of East Anglia (UK) where she studied the role of several protease families in cancer.
Dr Decock’s research focuses on advancing our current understanding of breast cancer to help accelerate the breast cancer field and advance the development of new treatments. Dr. Decock is the recipient of several research grants and her track-record includes over 2600 citations.